✦ LIBER ✦

OC.07.5: EFFICACY AND SAFETY OF INFLIXIMAB IN THE LONG-TERM IN CROHN'S DISEASE

✍ Scribed by W. Fries; A.C. Privitera; M.A. Lo Presti; M. Mastronardi; M. Cappello; L. Grossi; A. Lauria; M. Principi; N. Della Valle; N. Buccianti

Book ID: 119634483
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 46 KB
Volume: 43
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(11)60190-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P241 Long-term (5 years) efficacy and sa

P241 Long-term (5 years) efficacy and safety of infliximab in Crohn's disease patients

✍ R. Ferreiro; E. Fernandez-Salgado; V. Ollero; A. Lorenzo Gonzalez; D. Carpio; A. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 51 KB

OC.07.5 LONG-TERM SCHEDULED THERAPY WITH

OC.07.5 LONG-TERM SCHEDULED THERAPY WITH INFLIXIMAB IN INFLAMMATORY BOWEL DISEASE

✍ A. Armuzzi; M. Marzo; C. Felice; G. Mocci; F. De Vincentis; G. Andrisani; D. Pug 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Influence of Immunogenicity on the Long-

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

✍ Baert, Filip; Noman, Maja; Vermeire, Severine; Van Assche, Gert; D' Haens, Geert 📂 Article 📅 2003 🏛 Massachusetts Medical Society 🌐 English ⚖ 103 KB

Influence of immunogenicity on the long-

Influence of immunogenicity on the long-term efficacy of infliximab in Crohn’s disease

✍ Chinyu G Su; Gary R Lichtenstein 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Intensification of infliximab therapy in

Intensification of infliximab therapy in Crohn's disease: Efficacy and safety

✍ M.Chaparro; P. Martínez-Montiel; M. Van Domselaar; F. Bermejo; J.L. Pérez-Calle; 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 335 KB

Efficacy and safety of infliximab in 221

Efficacy and safety of infliximab in 221 Crohn’s disease patients

✍ Samir Shah A; David Fefferman S; Richard Farrell J; Mazen Alsahli; Parag Lodhavi 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 43 KB